Abstract
Lmo2 is a T cell leukemia-related proto-oncogene, which belongs to the LIM protein family. Previous work has established its key role in yolk sac erythropoiesis and adult hematopoiesis, and it is also necessary for regulating angiogenesis. It has been demonstrated that this gene encodes a protein of 158 amino acids, consisting of two tandem cysteine-rich LIM domains, but the detailed mechanism of its transcriptional regulation remains to be elucidated. To further investigate the mechanism of transcriptional regulation ofLmo2, we combined SMART PCR technology with 5′RACE and found a novel post-transcriptional splicing form ofLmo2 in adult human kidney. This alternative transcript contains only two exons, encoding a smaller protein of 151 amino acids. Interestingly, it shares the same reading frame as the originalLmo2, but differs in 7 amino acids at the N-terminus. Agenomic DNA fragment (from −294 nts to +180 nts) containing the putative promoter region has been inserted into the luciferase reporter gene vector pGL3-basic and showed stable promoter activity when transfected into COS7. RT-PCR analysis revealed that this variant transcript was expressed widely in human tissues and cell lines, suggesting its potential basic functional importance.
Similar content being viewed by others
References
Feuerstein, R., Wang, X., Song, D. et al., The LIM/double zinc-finger motif: A novel protein dimerization domain, Proc. Natl. Acad. Sci. USA, 1994, 91: 10655–10659.
Schmeichel, K. L., Beckerle, M. C., The LIM domain is a modular protein-binding interface, Cell, 1994, 79: 211–219.
Boehm, T., Foroni, L., Kaneko, Y. et al., The rhombotin family of cystein-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosome 11p15 and 11p13, Pro. Natl. Acad. Sci. USA, 1991, 88: 4367–4371.
Royer-Pokora, B., Uschi, L., Ludwig, W. D. et al., TTG-2, a new gene encoding a cysteine-rich protein with LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11), Oncogene, 1991, 6: 1887–1893.
Warren, A. J., Colledge, W. H., Carlton, M. B. et al., The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development, Cell, 1994, 78: 45–57.
Visvader, J. E., Mao, X. H., Fujuwara, Y. et al., The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation, Pro. Natl. Acad. Sci. USA, 1997, 94: 13707–13712.
Yamada, Y., Warren, A. J., Dobson, C. et al., The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis, Pro. Natl. Acad. Sci. USA, 1998, 95: 3890–3895.
Yamada, Y., Pannell, R., Alan, F. et al., The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice, Proc. Natl. Acad. Sci. USA, 2000, 97: 320–324.
Royer-Pokora, B., Rogers, M., Zhu, T. H. et al., The TTG-2/RBTN-2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p 13 translocations in acute T cell leukaemia’s (T-ALL), Oncogene, 1995, 10: 1353–1360.
Carninci, P., Nishiyama, Y., Westover, A. et al., Thermostabilization and thermo-activation of thermolabile enzymes by trehalose and its application for the synthesis of full length cDNA, Proc. Natl. Acad. Sci. USA, 1998, 95(1): 520–552.
Look, A. T., Oncogenic transcription factors in the human acute leukemias, Science, 1997, 278: 1059–1064.
Fitzgerald, T. J., Neale, G. A. M., Raimondi, S. C. et al., Rhom-2 expression does not always correlate with abnormalities on chromosome 11 at band p13 in T-cell acute lymphoblastic leukemia, Blood, 1992, 80: 3189–3197.
Robb, L., Lyons, I., Li, R. et al., Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene, Proc. Natl. Acad. Sci. USA. 1995, 92: 7075–7079.
Shivdasani, R. A., Mayer, E. L., Orkin, S. H., Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL, Nature, 1995, 373: 432–434.
Aplan, P. D., Jones, C. A., Chervinsky, D. S. et al., An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice, EMBO J, 1997, 16: 2408–2419.
Valge-Archer, V. E., Osada, H., Warren, A. J. et al., The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells, Pro. Natl. Acad. Sci. USA, 1994, 91: 8617–8621.
Wadman, I., Li, J., Bash, R. et al., Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia, EMBO J., 1994, 13: 4831–4839.
Wadman, I. A., Osada, H., Grutz, G. G. et al., The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA1 and Ldb1/NLI proteins, EMBO J., 1997, 16: 3145–3157.
Visvader, J. E., Mao, X. H., Fujiwara, Y. et al., The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation, Proc. Natl. Acad. Sci. USA, 1997, 94: 13707–13712.
Zhou, Y., Du, G. W., Wang, J. H. et al., The separation and cloning of human LDB1 cDNA, Chinese Science Bulletin, 1999, 44(8): 755–760.
Grutz, G. G., Bucher, K., Lavenir, I. et al., The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells, EMBO J., 1998, 17: 4594–4605.
Rabbitts, T. H., LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes, Gene & Dev., 1998, 12: 2651–2657.
Rabbitts, T. H., Bucher, K., Chung, G. et al., The effect of chromosomal translocations in acute leukemias: The LMO2 paradigm in transcription and development, Cancer Res., 1999, 39: 1794–1798.
Foroni, L., Boehm, T., White, L. et al., The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles on mouse development, J. Mol. Biol., 1992, 226: 747–761.
Bernard, O., Lecointe, N., Jonveaux, P. et al., Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′part of the TAL1 gene, Oncogene, 1991, 6: 1477–1488.
Cheng, J. T., Hsu, H. L., Hwang, L. Y. et al., Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues, Oncogene, 1993, 8: 677–683.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhu, T., Qin, G. & Royer-Pokora, B. A novel post-transcriptional splicing form of the acute T cell leukemia proto-oncogeneLmo2 . Sci. China Ser. C.-Life Sci. 44, 561–569 (2001). https://doi.org/10.1007/BF02879349
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02879349